(Q35622828)

9 August 2017

1 reference

title

Total skin electron beam radiotherapy for patients who have mycosis fungoides (English)

1 reference

9 August 2017

0 references

Glenn Jones

1

1 reference

PubMed ID

14710893

9 August 2017

Lynn D Wilson

series ordinal

2

1 reference

PubMed ID

14710893

9 August 2017

Lisa Fox-Goguen

series ordinal

3

1 reference

9 August 2017

1 December 2003

1 reference

Hematology / Oncology Clinics of North America

9 August 2017

1 reference

9 August 2017

17

1 reference

9 August 2017

6

1 reference

9 August 2017

1421-1434

1 reference

Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Total skin electron irradiation in mycosis fungoides dose and fractionation considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Radiotherapy in the management of mycosis fungoides: indications, results, prognosis. Twenty years experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Total skin electron beam and total nodal irradiation for treatment of patients with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Total skin electron beam and total nodal irradiation of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Combined total body X-ray irradiation and total skin electron beam radiotherapy with an improved technique for mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Cutaneous T-cell lymphoma (mycosis fungoides)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Implementation of total skin electron therapy using an optional high dose rate mode on a conventional linear accelerator

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Time to treatment failure as an end point for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Combined total body electron beam irradiation and chemotherapy for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Combined modality therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

The treatment of mycosis fungoides.Adjuvant topical mechlorethamine after electron beam therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900108-4

7 January 2021

10.1016/S0889-8588(03)00108-4

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14710893